Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5013837 | 0.79 | TSHR (0.39) | TSHRALDH1A1POLBADRB2MAPT | |
| SCHEMBL10652829 | 0.70 | — | — | |
| SCHEMBL809010 | 0.61 | — | — | |
| SCHEMBL1698052 | 0.60 | KMT2A (0.41) | TSHRALDH1A1 | |
| SCHEMBL4277832 | 0.60 | — | — | |
| SCHEMBL14019227 | 0.59 | — | — | |
| SCHEMBL15187605 | 0.59 | — | — | |
| SCHEMBL2012222 | 0.58 | — | — | |
| SCHEMBL294741 | 0.58 | — | — | |
| SCHEMBL9659277 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080293616-A1 | Use of 2-(1,1,4-Trimethylpent-3-Enyl)-4,7-Dihydro-1,3-Dioxepine | SYMRISE GMBH & CO. KG (DE) | 2008-11-27 | — | — | US | claimed |
| EP-1753851-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | Symrise GmbH & Co. KG (DE) | 2007-02-21 | — | — | EP | claimed |
| WO-2005103213-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | SYMRISE GMBH & CO. KG (DE) | 2005-11-03 | — | — | WO | claimed |
| US-20080293616-A1 | Use of 2-(1,1,4-Trimethylpent-3-Enyl)-4,7-Dihydro-1,3-Dioxepine | SYMRISE GMBH & CO. KG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080293616-A1 | Use of 2-(1,1,4-Trimethylpent-3-Enyl)-4,7-Dihydro-1,3-Dioxepine | SYMRISE GMBH & CO. KG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080293616-A1 | Use of 2-(1,1,4-Trimethylpent-3-Enyl)-4,7-Dihydro-1,3-Dioxepine | SYMRISE GMBH & CO. KG (DE) | 2008-11-27 | — | — | US | disclosed |
| EP-1992606-A1 | Alkene acetals and their use as odorous substances | Symrise GmbH & Co. KG (DE) | 2008-11-19 | — | — | EP | disclosed |
| EP-1753851-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | Symrise GmbH & Co. KG (DE) | 2007-02-21 | — | — | EP | disclosed |
| EP-1753851-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | Symrise GmbH & Co. KG (DE) | 2007-02-21 | — | — | EP | disclosed |
| EP-1753851-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | Symrise GmbH & Co. KG (DE) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005103213-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | SYMRISE GMBH & CO. KG (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005103213-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | SYMRISE GMBH & CO. KG (DE) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005103213-A1 | USE OF 2-(1,1,4-TRIMETHYLPENT-3-ENYL)-4,7-DIHYDRO-1,3-DIOXEPINE | SYMRISE GMBH & CO. KG (DE) | 2005-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293616-A1 | Use of 2-(1,1,4-Trimethylpent-3-Enyl)-4,7-Dihydro-1,3-Dioxepine | DBN1, DPY30, TPH1 | TSHR 4578/4885ALDH1A1 707/4885POLB 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.